These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 2190543)
21. Closed-loop glycemic control with a wearable artificial endocrine pancreas. Variations in daily insulin requirements to glycemic response. Shichiri M; Kawamori R; Hakui N; Yamasaki Y; Abe H Diabetes; 1984 Dec; 33(12):1200-2. PubMed ID: 6389235 [TBL] [Abstract][Full Text] [Related]
22. Pharmacodynamics and stability of subcutaneously infused glucagon in a type 1 diabetic Swine model in vivo. El-Khatib FH; Jiang J; Gerrity RG; Damiano ER Diabetes Technol Ther; 2007 Apr; 9(2):135-44. PubMed ID: 17425438 [TBL] [Abstract][Full Text] [Related]
23. The development of wearable-type artificial endocrine pancreas and its usefulness in glycaemic control of human diabetes mellitus. Shichiri M; Kawamori R; Hakui N; Asakawa N; Yamasaki Y; Abe H Biomed Biochim Acta; 1984; 43(5):561-8. PubMed ID: 6477542 [TBL] [Abstract][Full Text] [Related]
24. Production of Cloned Wuzhishan Miniature Pigs and Application for Alloxan Toxicity Test. Guo Q; Zhu HY; Jin L; Gao QS; Kang JD; Cui CD; Yin XJ Anim Biotechnol; 2015; 26(4):292-7. PubMed ID: 26158462 [TBL] [Abstract][Full Text] [Related]
25. The effect of portal and peripheral insulin delivery on carbohydrate and lipid metabolism in a miniature pig model of human IDDM. Canavan JP; Flecknell PA; New JP; Alberti KG; Home PD Diabetologia; 1997 Oct; 40(10):1125-34. PubMed ID: 9349592 [TBL] [Abstract][Full Text] [Related]
26. Continuous intravenous insulin therapy with a miniaturized open-loop system. Renner R; Hepp KD; Mehnert H; Franetzki M Horm Metab Res Suppl; 1979; (8):186-90. PubMed ID: 395077 [TBL] [Abstract][Full Text] [Related]
27. Large Animal Models of Diabetes. Ludwig B; Wolf E; Schönmann U; Ludwig S Methods Mol Biol; 2020; 2128():115-134. PubMed ID: 32180190 [TBL] [Abstract][Full Text] [Related]
28. Automated feedback control of subcutaneous glucose concentration in diabetic dogs. Rebrin K; Fischer U; von Woedtke T; Abel P; Brunstein E Diabetologia; 1989 Aug; 32(8):573-6. PubMed ID: 2673892 [TBL] [Abstract][Full Text] [Related]
29. Effect of peripheral versus portal venous administration of insulin on postprandial hyperglycemia and glucose turnover in alloxan-diabetic dogs. Rizza RA; Westland RE; Hall LD; Patton GS; Haymond MW; Clemens AH; Gerich JE; Service FJ Mayo Clin Proc; 1981 Jul; 56(7):434-8. PubMed ID: 7019592 [TBL] [Abstract][Full Text] [Related]
30. Integrated catheter system for continuous glucose measurement and simultaneous insulin infusion. Nacht B; Larndorfer C; Sax S; Borisov SM; Hajnsek M; Sinner F; List-Kratochvil EJ; Klimant I Biosens Bioelectron; 2015 Feb; 64():102-10. PubMed ID: 25194803 [TBL] [Abstract][Full Text] [Related]
32. [Assessment of self monitoring of blood glucose (SMBG) and continuous subcutaneous insulin infusion (CSII) in diabetic pregnant women]. Murata K; Toyoda N; Ito M; Rii T; Sugiyama Y; Miyamura Y Nihon Sanka Fujinka Gakkai Zasshi; 1985 Dec; 37(12):2749-57. PubMed ID: 4086905 [TBL] [Abstract][Full Text] [Related]
33. A portable, pre-programmable insulin infusion system in diabetes mellitus. Kølendorf K; Bojsen J Horm Metab Res Suppl; 1979; (8):191-3. PubMed ID: 395078 [TBL] [Abstract][Full Text] [Related]
34. Portable insulin infusion pumps as an alternative means of insulin delivery in type I diabetes. Report on 11 patients. Distiller LA S Afr Med J; 1983 Mar; 63(13):475-9. PubMed ID: 6340223 [TBL] [Abstract][Full Text] [Related]
35. Preprogrammed insulin infusion with a portable pump system. Irsigler K; Kritz H; Kaspar L; Brändle J; Koller W; Franetzki M Horm Metab Res Suppl; 1979; (8):193-7. PubMed ID: 119699 [TBL] [Abstract][Full Text] [Related]
36. Microfabricated microporous membranes reduce the host immune response and prolong the functional lifetime of a closed-loop insulin delivery implant in a type 1 diabetic rat model. Li J; Chu MK; Gordijo CR; Abbasi AZ; Chen K; Adissu HA; Löhn M; Giacca A; Plettenburg O; Wu XY Biomaterials; 2015 Apr; 47():51-61. PubMed ID: 25682160 [TBL] [Abstract][Full Text] [Related]
37. Hyperinsulinism complicating control of diabetes mellitus by an artificial beta-cell. Horwitz DL; Zeidler A; Gonen B; Jaspan JB Diabetes Care; 1980; 3(2):274-7. PubMed ID: 6993140 [TBL] [Abstract][Full Text] [Related]
38. Comparison of a perfusion syringe (Mill Hill Infusor) and a glucose-controlled insulin infusion system in the regulation of diabetes mellitus. Stavljenić A; Granić M; Topić B; Skrabalo Z Horm Metab Res Suppl; 1979; (8):207-11. PubMed ID: 395083 [TBL] [Abstract][Full Text] [Related]
39. Unstable diabetic state produced by a small dose of streptozotocin in rats. Simon OR; West ME West Indian Med J; 1992 Dec; 41(4):146-9. PubMed ID: 1290233 [TBL] [Abstract][Full Text] [Related]
40. A fuzzy logic based closed-loop control system for blood glucose level regulation in diabetics. Ibbini MS; Masadeh MA J Med Eng Technol; 2005; 29(2):64-9. PubMed ID: 15804854 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]